Breaking News Instant updates and real-time market news.

REGN

Regeneron

$376.40

5.44 (1.47%)

, SNY

Sanofi

$44.17

-0.62 (-1.38%)

15:28
04/21/17
04/21
15:28
04/21/17
15:28

EMA's CHMP issues positive opinion on Kevzara in rheumatoid arthritis

The Committee for Medicinal Products for Human Use, or CHMP, of the EMA announced it has adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Kevzara, intended for the treatment of rheumatoid arthritis.

REGN

Regeneron

$376.40

5.44 (1.47%)

SNY

Sanofi

$44.17

-0.62 (-1.38%)

  • 24

    Apr

  • 03

    May

REGN Regeneron
$376.40

5.44 (1.47%)

03/30/17
WEDB
03/30/17
NO CHANGE
Target $33
WEDB
Outperform
AnaptysBio price target raised to $33 from $28 at Wedbush
Wedbush analyst David Nierengarten raised his price target for AnaptysBio (ANAB) to $33 from $28 saying that Regeneron (REGN) and Sanofi's (SNY) Dupixent price suggests that higher pricing for the former's ANB020 could be achievable. The analyst reiterates an Outperform rating on AnaptysBio's shares.
03/29/17
UBSW
03/29/17
NO CHANGE
Target $446
UBSW
Buy
Regeneron target raised to $446 on higher than expected Dupixent pricing at UBS
UBS analyst Carter Gould noted that on the call related to Dupixent's approval for atopic dermatitis Regeneron (REGN) and Sanofi (SNY) said that the drug's annual $37K gross price was expected to translate into a net price in the "low $30K range" annually, which is above his prior estimate near $24K. Along with raising his annual net pricing assumption, Gould increased his peak sales estimate for Dupixent in atopic dermatitis to $3.1B from $2.8B and raised his price target on Regeneron to $446 from $435 while keeping a Buy rating on the stock.
03/29/17
FBCO
03/29/17
NO CHANGE
Target $485
FBCO
Outperform
Credit Suisse sees upside to Regeneron Dupixent if favorable payer environment
After FDA approved Regeneron (REGN) and Sanofi's (SNY) Dupixent, Credit Suisse analyst Alethia Young says that the pricing was higher than her expectations, but thinks that the peak opportunity is roughly around the same, remaining unchanged at $4.7B in 2025. Additionally, the analyst thinks that Regeneron/Sanofi upfront effort with payers may help early days of launch. She reiterates an Outperform rating and $485 price target on Regeneron's shares.
03/29/17
SBSH
03/29/17
NO CHANGE
Target $420
SBSH
Buy
Citi sees upside to consensus expectations for Dupixent launch
Citi analyst Robyn Karnauskas believes Regeneron Pharmaceuticals is taking a smart approach to the Dupixent launch by going after the sickest moderate to severe atopic dermatitis patients. A lack of payer pushback, which is the biggest investor concern, could make the launch look better than the street expectations of $138M for 2017, Karnauskas tells investors in a research note. She keeps a Buy rating on Regeneron with a $420 price target.
SNY Sanofi
$44.17

-0.62 (-1.38%)

04/11/17
04/11/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Conviction Buy from Buy at Goldman with analyst Drew Borst saying that the success of "Beauty and the Beast" has increased his confidence in his forecast that FY18 EPS growth will accelerate given the company's promising film slate and its read-through to consumer products. He also sees accelerating profit growth at ESPN given normalizing NBA costs and predicts record results for the Theme Parks segment. Borst keeps a $138 price target on Disney shares. 2. McDonald's (MCD) upgraded to Buy from Neutral at Cleveland Research. 3. Yelp (YELP) upgraded to Overweight from Sector Weight at Pacific Crest with analyst Brad Erickson saying his checks with local ad customers indicate Yelp's core franchise is healthy and appears insulated from larger competitors like Google (GOOG, GOOGL) and Facebook (FB). 4. Toll Brothers (TOL) upgraded to Outperform from Sector Perform at RBC Capital with analyst Robert Wetenhall citing "solid demand,strong execution, proven management, a strong luxury housing business, and consistent earnings." 5. Sanofi (SNY) upgraded to Neutral from Underweight at JPMorgan with analyst Richard Vosser saying he no longer sees downside to consensus estimates. The pressure on the diabetes business now seems largely reflected in estimates, Vosser tells investors in a research note. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/11/17
JPMS
04/11/17
UPGRADE
JPMS
Neutral
Sanofi upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Richard Vosser upgraded Sanofi to Neutral saying he no longer sees downside to consensus estimates. The pressure on the diabetes business now seems largely reflected in estimates, Vosser tells investors in a research note. The analyst raised his price target for the shares to EUR 87 from EUR 71.
04/07/17
RAJA
04/07/17
NO CHANGE
RAJA
Strong Buy
Flexion CMO hiring adds to Raymond James' skepticism of takeover speculation
Raymond James analyst Elliot Wilbur previously said he was skeptical of media-driven speculation that Sanofi (SNY) was preparing to bid for Flexion (FLXN), but he views the appointment of Yamo Deniz, another former Sanofi executive, as Flexion's chief medical officer as one more reason to doubt the rumor. Deniz "joins a growing roster of hires" from Sanofi and Wilbur does not believe these individuals, who "would have the best firsthand knowledge of exactly what the buzz is on Zilretta from the Sanofi perspective," would join Flexion simply to rejoin Sanofi again. While he thinks "some deflation" of the takeout premium in the stock could follow this hiring, Wilbur keeps a Strong Buy rating on Flexion shares.
04/07/17
04/07/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Lamb Weston (LW) downgraded to Hold from Buy at Stifel with analyst Christopher Growe citing the 44% up move in shares since he launched coverage in November 2016. 2. AstraZeneca (AZN), Novo Nordisk (NVO), Sanofi (SNY), Roche (RHHBY), and Grifols (GRFS) were downgraded to Reduce from Hold at HSBC. 3. AECOM (ACM) downgraded to Neutral from Outperform at Baird with analyst Andrew Wittmann saying the company filed an amendment to its credit agreement suggesting likely risk to 2017 earnings, as the filing implies the company would have breached its leverage covenant without an amendment. The analyst is also cautious given the relative obscurity of the filing. Wittmann lowered his price target to $40 from $45 on AECOM shares. 4. Arista Networks (ANET) downgraded to Neutral on valuation at Nomura with analyst Jeffrey Kvaal citing valuation. 5. Maximus (MMS) downgraded to Hold from Buy at Canaccord analyst Richard Close citing expectations of a slow near-term RFP and contract award environment given the recent Trump administration transition. click here.

TODAY'S FREE FLY STORIES

GOOS

Canada Goose

$20.60

-0.49 (-2.32%)

13:30
06/28/17
06/28
13:30
06/28/17
13:30
Upgrade
Canada Goose rating change  »

Canada Goose upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

13:25
06/28/17
06/28
13:25
06/28/17
13:25
Conference/Events
JPMorgan life sciences analyst holds an analyst/industry conference call »

Life Science Tools &…

MU

Micron

$31.66

-0.84 (-2.58%)

13:24
06/28/17
06/28
13:24
06/28/17
13:24
Hot Stocks
Nanya Technology lowers Micron stake to 4.17% with recent sale of 11.6M shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 29

    Aug

BPY

Brookfield Property

$24.08

0.34 (1.43%)

13:22
06/28/17
06/28
13:22
06/28/17
13:22
Conference/Events
Brookfield Property management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

13:20
06/28/17
06/28
13:20
06/28/17
13:20
General news
Treasury's $28 B 7-year auction results fell to the soft side »

Treasury's $28 B…

BPOP

Popular

$39.33

0.16 (0.41%)

13:19
06/28/17
06/28
13:19
06/28/17
13:19
Conference/Events
Popular management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 26

    Sep

  • 27

    Sep

$NSD

NASDAQ Market Internals

13:17
06/28/17
06/28
13:17
06/28/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MEOH

Methanex

$42.30

0.4 (0.95%)

13:16
06/28/17
06/28
13:16
06/28/17
13:16
Conference/Events
Methanex management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

$NYE

NYSE Market Internals

13:16
06/28/17
06/28
13:16
06/28/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
06/28/17
06/28
13:15
06/28/17
13:15
General news
Treasury Action: intermediate yields ticked higher »

Treasury Action:…

CS

Credit Suisse

$14.45

0.2 (1.40%)

13:14
06/28/17
06/28
13:14
06/28/17
13:14
Syndicate
Breaking Syndicate news story on Credit Suisse »

Credit Suisse files $85B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMGN

ImmunoGen

$6.54

-0.28 (-4.11%)

13:12
06/28/17
06/28
13:12
06/28/17
13:12
Conference/Events
ImmunoGen management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

VZ

Verizon

$44.85

0.005 (0.01%)

, GOOG

Alphabet

$927.33

-24.94 (-2.62%)

13:09
06/28/17
06/28
13:09
06/28/17
13:09
Periodicals
Verizon explores pooling consumer data with other wireless firms, BI says »

After closing its…

VZ

Verizon

$44.85

0.005 (0.01%)

GOOG

Alphabet

$927.33

-24.94 (-2.62%)

GOOGL

Alphabet Class A

$948.09

-24 (-2.47%)

FB

Facebook

$150.58

-3.01 (-1.96%)

TMUS

T-Mobile

$61.01

-2.14 (-3.39%)

S

Sprint

$8.14

-0.04 (-0.49%)

VOD

Vodafone

$28.65

-0.145 (-0.50%)

TEF

Telefonica

$10.53

-0.1 (-0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

  • 27

    Jul

  • 03

    Aug

MIC

Macquarie Infrastructure

$79.18

0.8299 (1.06%)

13:09
06/28/17
06/28
13:09
06/28/17
13:09
Conference/Events
Macquarie Infrastructure management to meet with RBC Capital »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 18

    Jul

  • 19

    Jul

13:05
06/28/17
06/28
13:05
06/28/17
13:05
General news
7-Yr Note Auction Coupon Rate data reported »

7-Yr Note Auction Coupon…

13:05
06/28/17
06/28
13:05
06/28/17
13:05
General news
7-Yr Note Auction Total Amount data reported »

7-Yr Note Auction Total…

13:05
06/28/17
06/28
13:05
06/28/17
13:05
General news
Treasury Option Action: bullish 10-year positioning »

Treasury Option Action:…

MTCH

Match Group

$17.50

-0.295 (-1.66%)

13:04
06/28/17
06/28
13:04
06/28/17
13:04
Hot Stocks
Tinder introduces Tinder Gold premium service »

Match Group's Tinder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAD

Rite Aid

$4.04

0.2989 (7.99%)

, WBA

Walgreens Boots Alliance

$77.26

-0.27 (-0.35%)

13:02
06/28/17
06/28
13:02
06/28/17
13:02
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

RAD

Rite Aid

$4.04

0.2989 (7.99%)

WBA

Walgreens Boots Alliance

$77.26

-0.27 (-0.35%)

MKC

McCormick

$98.40

-0.135 (-0.14%)

LNN

Lindsay

$87.92

1.32 (1.52%)

GBX

Greenbrier

$50.15

0.7 (1.42%)

CAG

Conagra Brands

$37.53

0.525 (1.42%)

STZ

Constellation Brands

$183.93

1.65 (0.91%)

AYI

Acuity Brands

$180.03

4.695 (2.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 07

    Jul

GOOG

Alphabet

$927.33

-24.94 (-2.62%)

, GOOGL

Alphabet Class A

$948.09

-24 (-2.47%)

13:02
06/28/17
06/28
13:02
06/28/17
13:02
Periodicals
Alphabet sought to sell Nest last year, Reuters reports »

At a certain point in…

GOOG

Alphabet

$927.33

-24.94 (-2.62%)

GOOGL

Alphabet Class A

$948.09

-24 (-2.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

PIR

Pier 1 Imports

$5.42

0.0799 (1.50%)

, SHLM

A. Schulman

$27.50

-1.05 (-3.68%)

13:02
06/28/17
06/28
13:02
06/28/17
13:02
Earnings
Notable companies reporting after market close »

Notable companies…

PIR

Pier 1 Imports

$5.42

0.0799 (1.50%)

SHLM

A. Schulman

$27.50

-1.05 (-3.68%)

PRGS

Progress Software

$30.08

-0.16 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 29

    Jun

AMZN

Amazon.com

$976.78

-17.2 (-1.73%)

, GOOG

Alphabet

$927.33

-24.94 (-2.62%)

13:00
06/28/17
06/28
13:00
06/28/17
13:00
Hot Stocks
Best Buy to launch Amazon Alexa, Google Home 'experiences' in 700 stores »

Best Buy (BBY) announced…

AMZN

Amazon.com

$976.78

-17.2 (-1.73%)

GOOG

Alphabet

$927.33

-24.94 (-2.62%)

GOOGL

Alphabet Class A

$948.09

-24 (-2.47%)

BBY

Best Buy

$56.96

0.78 (1.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

  • 29

    Aug

CPN

Calpine

$13.83

0.07 (0.51%)

13:00
06/28/17
06/28
13:00
06/28/17
13:00
Options
Notable put buying in Calpine »

Notable put buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

P

Pandora

$8.95

0.455 (5.36%)

, AAPL

Apple

$143.73

-2.09 (-1.43%)

12:58
06/28/17
06/28
12:58
06/28/17
12:58
Periodicals
Pandora CEO: Company can withstand Spotify, Apple Music competition, HR says »

Pandora (P) interim CEO…

P

Pandora

$8.95

0.455 (5.36%)

AAPL

Apple

$143.73

-2.09 (-1.43%)

SIRI

SiriusXM

$5.26

-0.04 (-0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

SIG

Signet Jewelers

$63.08

0.08 (0.13%)

12:55
06/28/17
06/28
12:55
06/28/17
12:55
Options
Signet Jewelers put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.